New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export BMY’s income statement to Excel — free account
Bristol Myers Squibb Company
BMYHealthcare Drug Manufacturers General
Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- +6.93%
- EPS
- −2.78%
- Free cash flow
- −36.0%
- Total debt
- −12.5%
Quarter to September 2026, against a year earlier
59.45
1.11
+1.90%
Follow BMY
Alert me
Bristol Myers Squibb Company (BMY) SEC filings, changes and red flags
Red flags
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 11 added · 7 removed · 38 modified P2I1A: no material changes, the filing says |
||
| 8-K | Oct 29, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2026 |
P1I2: 11 added · 9 removed · 42 modified P2I1A: no material changes, the filing says |
||
| 8-K | Jul 30, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | May 5, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 10-Q | Mar 31, 2026 |
P1I2: 33 added · 86 removed · 30 modified P2I1A: no material changes, the filing says |
||
| 8-K | Apr 30, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2025 |
1: 10 added · 8 removed · 52 modified 1A: 4 added · 1 removed · 51 modified 7: 55 added · 50 removed · 74 modified |
||
| 8-K | Feb 5, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 12, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 17, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 31, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 3, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 |
P1I2: 14 added · 17 removed · 53 modified P2I1A: no material changes, the filing says |
||
| 8-K | Oct 30, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 |
P1I2: 28 added · 11 removed · 56 modified P2I1A: no material changes, the filing says |
||
| 8-K | Jul 31, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 | |||
| 8-K | Apr 24, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 |
1: no comparison — no earlier filing on file 1A: no comparison — no earlier filing on file 7: no comparison — no earlier filing on file |
||
| 8-K | Feb 6, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Oct 31, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Jul 26, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Apr 25, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Feb 2, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits |